CYTOPENIA
Clinical trials for CYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CYTOPENIA trials appear
Sign up with your email to follow new studies for CYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare blood disorder
Disease control Recruiting nowThis study is testing whether giving the drug emapalumab early can help children and young adults newly diagnosed with severe aplastic anemia. The goal is to see if this initial treatment improves blood counts and makes standard follow-up treatments more effective. The trial will…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 19:40 UTC
-
New drug tested to rescue patients from dangerous CAR-T side effect
Disease control Recruiting nowThis study is testing a drug called emapalumab to see if it can safely treat a serious side effect of CAR-T cancer therapy. The side effect, called prolonged severe cytopenia, causes dangerously low blood cell counts. The trial will enroll 32 adults with lymphoma who developed th…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Targeted radiation tested for prostate cancer patients with dangerous blood counts
Disease control Recruiting nowThis study is testing a targeted radiation drug called 177Lu-PSMA-617 in men with advanced prostate cancer that has spread to the bone marrow and caused low blood cell counts. The main goal is to see if the treatment is safe and effective for this specific group of patients who o…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug aims to boost blood cell production in bone marrow disorder
Disease control Recruiting nowThis study is testing an investigational drug called KER-050 (elritercept) to see if it can safely help the body make more healthy red blood cells in adults with lower-risk myelodysplastic syndromes (MDS) who have anemia. The main goals are to check the drug's safety and see if i…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Needle prick could replace painful bone marrow tests for blood cancer diagnosis
Diagnosis Recruiting nowThis study aims to create a simple blood test that could replace painful bone marrow biopsies for diagnosing myelodysplastic syndrome (MDS) and other blood cell deficiencies. Researchers will collect blood samples from 1,500 adults who are already scheduled for bone marrow evalua…
Matched conditions: CYTOPENIA
Sponsor: Weizmann Institute of Science • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
Genetic sleuthing aims to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study aims to find people at risk for developing blood cancers and bone marrow failure syndromes before they get sick. Researchers will use advanced genetic testing on blood, bone marrow, and saliva samples from up to 2,000 participants. The goal is to identify early warning…
Matched conditions: CYTOPENIA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC